Stay updated on JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial
Sign up to get notified when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.

Latest updates to the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe revision label in the page footer updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the administrative notice banner about a lapse in government funding and NIH operating status. The study details and trial information shown on the page remain the same.SummaryDifference0.4%

- Check34 days agoChange DetectedResults data for the study were posted, including primary and secondary outcomes across ABI, SRS-2, ABC, CGI scales, and related measures. The record dates show Results First Posted on 2025-04-23 and subsequent updates.SummaryDifference0.4%

- Check63 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference2%

- Check70 days agoChange DetectedPage now shows revision to v3.1.0 and removes several drug-safety-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a shift away from those topics while adding a new version.SummaryDifference0.2%

- Check84 days agoChange DetectedUpdated to v3.0.2 from v3.0.1 and removed the Back to Top element. This is a minor release with no changes to core content, pricing, stock, or time-sensitive information.SummaryDifference0.1%

Stay in the know with updates to JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.